Difference between revisions of "User:Jeremy S. Myers"

From OpenWetWare
(Research interests)
 
(13 intermediate revisions by the same user not shown)
Line 1: Line 1:
<!-- Delete this entire line as part of your first edit of your user page --> {{New user}}
 
 
 
==Contact Info==
 
==Contact Info==
[[Image:OWWEmblem.png|thumb|right|Jeremy S. Myers (an artistic interpretation)]]
+
[[Image:OWWEmblem.png|thumb|right|(an artistic interpretation)]]
  
*Jeremy S. Myers
+
*Jeremy S. Myers, Ph.D.
 +
*AstraZeneca Fellow
 +
*Advanced Targeted Proteomics Team Leader
 
*Vanderbilt University School of Medicine
 
*Vanderbilt University School of Medicine
*Address 1
+
*Mass Spectrometry Research Center
*Address 2
+
*Nashville, TN, U.S.A.  
*City, State, Country etc.  
+
*jeremy.myers@vanderbilt.edu
*[[Special:Emailuser/Jeremy S. Myers|Email me through OpenWetWare]]
 
  
I work in the [[Your Lab]] at XYZ University. I learned about [[OpenWetWare]] from I located OWW using google while trying to identify available electronic lab notebook wiki resources , and I've joined because to develop and distribute laboratory protocols.
+
for more information visit:  http://www.advancedtargetedproteomics.com
  
 
==Education==
 
==Education==
 
<!--Include info about your educational background-->
 
<!--Include info about your educational background-->
* Year, PhD, Institute
+
* 2003-2007  Postdoctoral Fellow
* Year, MS, Institute
+
* 2003  Ph.D., Louisiana State University
* Year, BS, Institute
+
* 1999  B.S., Bucknell University
  
 
==Research interests==
 
==Research interests==
 
<!-- Feel free to add brief descriptions to your research interests as well -->
 
<!-- Feel free to add brief descriptions to your research interests as well -->
# Proteomic Analysis of DNA Damage Response Signaling Pathways
+
# Targeted Mass Spectrometry-based Proteomics
# Mass Spectrometry Analysis of Protein Posttranslation Modifications
+
# Targeted Therapeutics
  
==Publications==
+
==Publications (since 2007)==
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed -->
+
#Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878
<biblio>
 
#Paper1 pmid=6947258
 
#Paper2 pmid=13718526
 
// leave a comment about a paper here
 
#Book1 isbn=0879697164
 
</biblio>
 
  
 
==Useful links==
 
==Useful links==
 
*[[OpenWetWare:Welcome|Introductory tutorial]]
 
*[[OpenWetWare:Welcome|Introductory tutorial]]
 
*[[Help|OpenWetWare help pages]]
 
*[[Help|OpenWetWare help pages]]
 +
 +
==Selected Protocols==
 +
*[[Myers:EGFR_IP]]
 +
*[[Myers:synchronization]]

Latest revision as of 08:20, 14 August 2008

Contact Info

(an artistic interpretation)
  • Jeremy S. Myers, Ph.D.
  • AstraZeneca Fellow
  • Advanced Targeted Proteomics Team Leader
  • Vanderbilt University School of Medicine
  • Mass Spectrometry Research Center
  • Nashville, TN, U.S.A.
  • jeremy.myers@vanderbilt.edu

for more information visit: http://www.advancedtargetedproteomics.com

Education

  • 2003-2007 Postdoctoral Fellow
  • 2003 Ph.D., Louisiana State University
  • 1999 B.S., Bucknell University

Research interests

  1. Targeted Mass Spectrometry-based Proteomics
  2. Targeted Therapeutics

Publications (since 2007)

  1. Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878

Useful links

Selected Protocols